Karin Tunblad

Karin Tunblad has a diverse and extensive work experience in the pharmaceutical industry. Karin began their career in 2004 as a Post doc at Uppsala University, Department of Pharmacokinetics and Drug Therapy. Karin then worked as a Pharmacokinetic assessor at the Medical Products Agency from 2005 to 2006. In 2006, they joined AstraZeneca R&D as an Associate Principal Scientist PK &PKPD, where they worked until 2012. During this time, they gained experience in drug development and analysis. In 2012, Karin joined Medivir AB as an In vivo PK and PK/PD Scientist 5, and later took on the role of Senior Principal Scientist. Currently, they hold the position of Project Director at Medivir AB. Karin Tunblad has demonstrated expertise in pharmacokinetics and drug therapy, contributing significantly to the field through their various roles.

Karin Tunblad has a strong educational background in the field of pharmacy and pharmacokinetics. Karin obtained their Bachelor's degree in Pharmaceutical Sciences from Uppsala University, where they studied from 1993 to 1999. Building upon their undergraduate studies, they pursued a Doctorate degree in Pharmacokinetics and Drug Therapy at the same university. Karin'sPhD program lasted from 1999 to 2004. Overall, Karin Tunblad's education history showcases their commitment to understanding drug therapy and its impact on the human body.